Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| TACD2 | P09758 | Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1) | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | AmyloidosisCorneal dystrophyBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 16 | 0.47 | ||
| TGM1 | P22735 | Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1) [Cleaved into: Protein-glutamine gamma-glutamyltransferase K 67 kDa chain; Protein-glutamine gamma-glutamyltransferase K 33 kDa chain] | Disease related genesEnzymesHuman disease related genes | IchthyosisAutosomal Recessive Ichthyosis | Clinical-translation mediation | 16 | 0.47 | |||
| XYLT1 | Q86Y38 | Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I) | Disease related genesEnzymesHuman disease related genes | 1 | Dwarfism | Metabolism mediation | 16 | 0.47 | ||
| MP2K1 | Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) | Cancer-related genesDisease related genesEnzymes | CardiomyopathyEctodermal dysplasiaIntellectual disability | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 15 | 0.47 | |||
| WASP | P42768 | Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp) | Cancer-related genesDisease related genesHuman disease related genes | Qualitative platelet defect | Clinical-translation mediationFusion and delivery mediationImmune mediation | 15 | 0.47 | |||
| PPBT | P05186 | Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) | Cancer-related genesDisease related genesEnzymes | Colon cancerGenetic prion diseaseMineral absorption/transport disorder | Clinical-translation mediationImmune mediationMetabolism mediation | 13 | 0.47 | |||
| ACE2 | Q9BYF1 | Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2] | EnzymesMetabolic proteinsPredicted membrane proteins | 1 | Acute diabetic complicationIntrathoracic organs injuryPulmonary hypertension | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 0 | 0.47 | ||
| AQP2 | P41181 | Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct) | Disease related genesHuman disease related genesMetabolic proteins | 6 | Diabetes insipidus | Fusion and delivery mediationMetabolism mediation | 0 | 0.47 | ||
| CAD23 | Q9H251 | Cadherin-23 (Otocadherin) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | DeafnessNon-syndromic deafnessRetinitis pigmentosa | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 0 | 0.47 | ||
| CCR5 | P51681 | C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195) | 7 | Chronic kidney diseaseChronic obstructive pulmonary diseaseDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.47 |